Pharmaxi

Pharmaxi

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Pharmaxi LLC is a private, revenue-generating contract research organization (CRO) providing clinical trial services across Eastern and Central Europe, primarily in Ukraine and Poland. Its core business is the full-service management of late-phase (Phase III-IV) clinical trials and post-marketing studies, supported by its proprietary OnlineCRF platform for efficient data management and site oversight. The company leverages the cost-attractive and patient-rich clinical trial environments of its operating regions, positioning itself as a flexible and innovative partner for sponsors. While it does not develop its own therapeutics, its service model and proprietary technology platform are its key assets.

Drug DeliverySmall Molecules

Technology Platform

Proprietary Electronic Data Capture (EDC) system called OnlineCRF, enabling remote data management, role-based oversight, real-time analytics, and enhanced data quality for clinical trials.

Opportunities

The company is positioned to capitalize on the growing demand for cost-effective and patient-accessible clinical trial locations in Eastern and Central Europe.
Its proprietary OnlineCRF platform provides a technological edge for operational efficiency and client transparency, differentiating it from competitors.

Risk Factors

Extreme geopolitical risk due to operations in Ukraine during an ongoing war, which threatens business continuity, employee safety, and client confidence.
Additional risks include high competition in the CRO sector, reliance on specific geographic markets, and operational execution risks inherent in clinical research.

Competitive Landscape

Pharmaxi competes in the fragmented global CRO market, facing competition from large multinational CROs (e.g., IQVIA, ICON) and numerous regional and niche players in Eastern Europe. Its differentiation is based on deep local expertise in Ukraine/Poland, a flexible service model, and its proprietary OnlineCRF technology platform.